| Literature DB >> 25229055 |
Mats-Olof Mattsson1, Myrtill Simkó1.
Abstract
A large body of literature deals with biological effects of extremely low-frequency magnetic fields (ELF MFs) studied in vitro. Despite the multitude of studies, no coherent picture has evolved regarding the plausibility of effects at low-flux densities or regarding the interaction mechanisms. Here, we propose that ELF MF exposure in vitro causes changes in oxidative status as an early response. We tested this hypothesis by scrutinizing the literature and applying a grouping approach for analyzing relevant biological properties and exposure conditions. A total of 41 scientific original publications were analyzed for this purpose. The conclusion from the work is that ELF MF (modulated or unmodulated) consistently can influence the oxidative status, at or above 1 mT, in a broad range of cell types and independent of exposure duration. A response at lower flux densities is seen in certain studies, although not consistently. Further studies with stringent protocols for sham exposure, blinding, and statistical analysis as well as appropriate positive controls are needed to establish if true dose-relationships for effects on oxidative status exist.Entities:
Keywords: ROS; exposure duration; flux density; immune-relevant cells; mammalian cells
Year: 2014 PMID: 25229055 PMCID: PMC4151017 DOI: 10.3389/fpubh.2014.00132
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Summary of identified relevant studies.
| Cells | Exposure conditions | Oxidative response | Reference | |||
|---|---|---|---|---|---|---|
| Human peripheral blood mononuclear cells | Mononuclear cells | Primary | Immune relevant | 20–5000 Hz 5 μT 30 min | No | ( |
| Human peripheral blood mononuclear cells | Mononuclear cells | Primary | Immune relevant | 50 or 60 Hz 2, 20, 100, 500 μT 6 h | No | ( |
| MCF10A human breast epithelial cells | Breast epithelial cells | Cell line | Other cell line | 60 Hz 1 mT 4 h | No | ( |
| Murine L929 fibroblasts | Fibroblasts | Cell line | Other cell line | 50 Hz 100 or 300 μT 1 or 24 h | No | ( |
| Rat-cortical neurons | Neurons | Primary | Other primary cells | 50 Hz 0.1 and 1.0 mT 7 days | No | ( |
| Rabbit red blood cells | Red blood cells | Primary | Other primary cells | 50 Hz 0.2, 0.5 mT 45, 90 min | No | ( |
| THP-1 cells (human monocytic leukemia cell line) | Leukemia | Cell line | Immune relevant | 50 Hz 1 mT 4 h | Yes | ( |
| K562 cells | Myelogenous leukemia | Cell line | Immune relevant | 50 Hz 1 mT 3 h | Yes | ( |
| K562 cells | Myelogenous leukemia | Cell line | Immune relevant | 50 Hz 5 mT 1 h | Yes | ( |
| Murine osteoblasts (7F2) co-cultured with RAW 264.7 macrophages | Osteoblasts, macrophages | Cell line | Immune relevant | 75 Hz, PEMF 1.5 mT 9 h | Yes | ( |
| Human mono Mac 6 cells | Monocytic leukemia | Cell line | Immune relevant | 50 Hz | Yes | ( |
| Human umbilical cord blood-derived monocytes | Monocytes | Primary | 1 mT 45 min | |||
| K562 cells | Myelogenous leukemia | Cell line | Immune relevant | 50 Hz 0.025–0.10 mT 1 h | Yes | ( |
| THP-1 | Monocytic cells | Cell line | Immune relevant | 50 Hz 1 mT 6, 24 h | Yes | ( |
| Primary mouse macrophages | Macrophages | Primary | Immune relevant | 50 Hz 0.05–1.0 mT 45 min–48 h | Yes | ( |
| Mouse macrophages from isolated bone marrow precursor cells | Macrophages | Primary | Immune relevant | 50 Hz 1 mT 5 min–24 h | Yes | ( |
| Human blood platelets from voluntary donors | Platelets | Primary | Immune relevant | 50 Hz 10 mT 15 min | Yes | ( |
| Human peripheral blood mononuclear cell | Mononuclear cells | Primary | Immune relevant | 50 Hz 1, 3, 10, 30 mT 3 days | Yes | ( |
| Human peripheral blood mononuclear cell from Cohn’s disease patients | Mononuclear cells | Primary | Immune relevant | PEMF 50 Hz 45 mT 3 h/day × 3 h/day | Yes | ( |
| Human umbilical cord blood-derived monocytes | Monocytes | Primary | Immune relevant | 50 Hz 1 mT 5–45 min | Yes | ( |
| Peritoneal neutrophils isolated from male SD rats | Neutrophils | Primary | Immune relevant | 60 Hz 0.1 and 2.0 mT up to 1000 s | Yes | ( |
| Human peripheral blood neutrophils | Neutrophils | Primary | Immune relevant | 180–195 Hz PEMF 10, 40, 60 μT n.n. | Yes | ( |
| Human monocyte | Monocytes | Primary | Immune relevant | 50 Hz 1 mT Overnight | Yes | ( |
| Mouse bone marrow-derived promonocytes and macrophages | Macrophages | Primary | Immune relevant | 50 Hz 1 mT 45 min or 24 h | Yes | ( |
| Peritoneal neutrophils from SD rats (primed) | Neutrophils | Primary | Immune relevant | 60 Hz 0.1 mT up to 600 s | Yes | ( |
| Murine bone marrow-derived macrophages | Macrophages | Primary | Immune relevant | 50 Hz 1.0 mT 45 min | Yes | ( |
| Human peripheral blood neutrophils | Neutrophils | Primary | Immune relevant | 75 Hz PEMF 2.5 mT 60 min | Yes | ( |
| Lymphocytes from male albino Wistar rats | Lymphocytes | Primary | Immune relevant | 50 Hz 20, 40, 200 μT 1 h | Yes | ( |
| AT478 murine squamous cell carcinoma cells | Squamous cell carcinoma | Cell line | Other cell line | 50 Hz 1 mT 16 min | Yes | ( |
| Human colon adenocarcinoma cells (Caco 2) | Colon adenocarcinoma | Cell line | Other cell line | 50 Hz 1 mT 24, 48, 72 h | Yes | ( |
| Human SH-SY5Y neuroblastoma cells | Neuroblastoma | Cell line | Other cell line | 50 Hz 1 mT 1 h | Yes | ( |
| Human prostate cancer cell lines DU145, PC3, LNCaP | Prostate cell lines | Cell line | Other cell line | 60 Hz 1 mT 3, 6, 24, 48, 72 h | Yes | ( |
| Human SH-SY5Y neuroblastoma cells | Neuroblastoma cells | Cell line | Other cell line | 50 Hz 0.1 mT 24 h | Yes | ( |
| PC12 cells | Neuronal pheochromocytoma | Cell line | Other cell line | 50 Hz 0.1 or 1.0 mT 30 min 1–7 days | Yes | ( |
| C2C12 cells (muscle cells) | Myoblast | Cell line | Other cell line | 50 Hz 0.1 and 1.0 mT 5 and 30 min | Yes | ( |
| Human keratinocyte cells HaCaT | Keratinocytes | Cell line | Other cell line | 50 Hz 1 mT 3, 18, or 48 h | Yes | ( |
| AT478 murine squamous cell carcinoma line | Squamous cell carcinoma | Cell line | Other cell line | 400 Hz 0.11 mT 16 min | Yes | ( |
| Human keratinocyte cell line HaCaT | Keratinocytes | Cell line | Other cell line | 50 Hz 1 mT 4, 12, 72 h | Yes | ( |
| Rat-1 fibroblasts | Fibroblasts | Cell line | Other cell line | 50 Hz 1.0 mT 3 or 24 h | Yes | ( |
| AT478 murine squamous cell carcinoma line | Squamous cell carcinoma | Cell line | Other cell line | 3 Hz−3 kHz 0.11 mT 16 min | Yes | ( |
| 3T3-L1 preadipocytes | Preadipocytes | Cell line | Other cell line | 180–195 Hz PEMF 0.12 mT 36 min | Yes | ( |
| Human bone marrow mesenchymal stem cells (hBM–MSCs) | Mesenchymal stem cells | Primary | Other primary cells | 50 Hz 1 mT 90 min | Yes | ( |
.
Figure 1Oxidative response as a positive or negative finding after exposure to ELF MF in different cell types.
Figure 2Oxidative response as a positive or negative finding after exposure to non-modulated or modulated ELF MF in different cell types.
Figure 3Oxidative response as a positive or negative finding after exposure to different flux densities of ELF MF in different cell types.
Figure 4Oxidative response as a positive or negative finding after different exposure durations to ELF MF in different cell types.
Figure 5The use of positive controls in investigating oxidative response as a positive or negative finding after exposure to ELF MF.
Figure 6Reactive oxygen species production as a measure of “effect size” after exposure to ELF MF. The direction of change (increase: up and decrease: down) has been considered.